News
BLGO
0.166
-3.43%
-0.006
BioLargo reports FY results
Seeking Alpha · 1d ago
BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures
Seeking Alpha · 2d ago
BioLargo Issues Investor Presentation Under Regulation FD Disclosure
TipRanks · 2d ago
BioLargo FY 2025 net loss widens 249% to USD 15.2 million
Reuters · 3d ago
BioLargo Inc. Updates Financial Calendar
Reuters · 3d ago
Weekly Report: what happened at BLGO last week (0223-0227)?
Weekly Report · 5d ago
Weekly Report: what happened at BLGO last week (0216-0220)?
Weekly Report · 02/23 09:32
BioLargo’s Clyra Medical highlights KOL presentation on ViaCLYR results
TipRanks · 02/18 12:37
Most and least shorted materials stocks with up to $2B market cap
Seeking Alpha · 02/18 04:47
Weekly Report: what happened at BLGO last week (0209-0213)?
Weekly Report · 02/16 09:32
BioLargo’s Clyra Medical secures first stocking order for ViaCLYR
TipRanks · 02/09 14:15
BioLargo Subsidiary Clyra Medical Receives First Commercial Order for ViaCLYR Wound Solution
Reuters · 02/09 14:00
Weekly Report: what happened at BLGO last week (0202-0206)?
Weekly Report · 02/09 09:33
Weekly Report: what happened at BLGO last week (0126-0130)?
Weekly Report · 02/02 09:32
BioLargo installs AEC PFAS treatment system at Lake Stockholm, New Jersey
TipRanks · 01/27 14:10
Weekly Report: what happened at BLGO last week (0119-0123)?
Weekly Report · 01/26 09:32
Weekly Report: what happened at BLGO last week (0112-0116)?
Weekly Report · 01/19 09:36
BioLargo Inc. to Present at Sidoti's Micro-Cap Virtual Conference
Reuters · 01/16 11:30
Weekly Report: what happened at BLGO last week (0105-0109)?
Weekly Report · 01/12 09:34
Weekly Report: what happened at BLGO last week (1229-0102)?
Weekly Report · 01/05 09:33
More
Webull provides a variety of real-time BLGO stock news. You can receive the latest news about Biolargo through multiple platforms. This information may help you make smarter investment decisions.
About BLGO
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company’s core products address polyfluoroalkyl substances (PFAS) contamination, achieve advanced water and wastewater treatment, control odor and VOCs. The Company operates in distinct business segments, including ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services; Clyra Medical, which develops and sells medical products based on its technology; BETI, which develops its battery technology; BEST, which sells equipment based on its technology; BioLargo Canada, located in Edmonton, Alberta, Canada, has its primary research and development activities; and corporate operations, which support the operating segments with legal, accounting, human resources, and other services.